搜尋結果
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 32 分鐘前Analyst Hardik Parikh initiated research coverage on the clinical stage drug developer with an ...
Many Quit Weight-Loss Drugs Too Early for Benefits, Insurer Says
Bloomberg· 3 小時前Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t ...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 8 小時前, opens new tab experimental drug met its primary goal of reducing asthma attacks in a ...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 10 小時前An experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 7 小時前The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in ...
Nestlé Courts People Taking Weight-Loss Drugs With Frozen Pizza
Bloomberg· 2 小時前Nestlé SA is launching a new line of frozen foods specifically targeting users of GLP-1 drugs like Ozempic and Mounjaro, ...
Opinion | Switch Off ‘Stress Chemicals’ to Lose Weight—and Keep It Off
The Wall Street Journal· 2 日前The root cause of overeating and weight gain is stress, which amplifies our shared genetic ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 7 小時前... our reporters? China gave the greenlight to Eli Lilly & Co.’s blockbuster drug</ ... ...
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
CNBC· 4 小時前Over the last year, the buzzy weight loss and diabetes drugs have taken off as more options hit ...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 8 小時前Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the ...